<DOC>
	<DOCNO>NCT02196805</DOCNO>
	<brief_summary>This study compare pharmacokinetics characteristic single oral intake import PROBUCOL tablet ( Lorelco ) ( 1*250mg/tablet ) market PROBUCOL tablet ( Chang Tai ) ( 1*250mg/tablet ) healthy male volunteer demonstrate bioequivalent .</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Single Oral Intake Imported PROBUCOL Tablet ( Lorelco ) With Marketed PROBUCOL Tablet ( Chang Tai ) Chinese Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Probucol</mesh_term>
	<criteria>Chinese Male , age 18 40 year ( time inform consent ) , extremes included Nonsmokers Normal weight define Quetelet body mass index range 18.0 26.0 kg/m2 , extremes included Subjects judge investigator sub investigator healthy base physical examination , medical history , vital sign , electrocardiogram ( ECG ) , result clinical laboratory test Provided sign informed consent prior begin protocolspecific procedure , indicate understood purpose study Willing adhere study procedure describe protocol History respiratory system disease , cardiovascular disease , Renal Urogenital Disease , Gastrointestinal disease , hematological disease , Neuropsychiatric disease , endocrine disease , hepatic disease disease physical condition could interfere interpretation study result Known hypersensitivity history prescription drug overthecounter medication Use follow medication product period specify : Any medication within 14 day prior schedule study drug administration ; Alcohol caffeine within 7 day prior schedule study drug administration ; Grapefruit grapefruit product within 14 day prior schedule study drug administration Participation clinical trial within 12 week prior schedule study drug administration , intention participate clinical trial course study Significant loss donation blood plasma ( 200 mL ) within 30 day prior start study Body weight &lt; 50kg History drug abuse within past 5 year positive urine drug screen result Subjects test positive HIV , HCV antibody , HBS antigen Otherwise judge investigator inappropriate inclusion study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>import PROBUCOL table</keyword>
	<keyword>Lorelco</keyword>
	<keyword>market PROBUCOL tablet</keyword>
	<keyword>Chang Tai</keyword>
</DOC>